Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Tirzepatide
History
Tirzepatide is a synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It was developed to improve blood glucose control while also promoting weight loss through multiple metabolic pathways.
Research Use
Researchers study Tirzepatide for its potential effects on:
Blood glucose regulation
Weight management
Appetite control
Insulin sensitivity
Cardiometabolic health
Body composition
Clinical Highlights
Studied for improving blood sugar control by enhancing glucose-dependent insulin secretion
Investigated for promoting significant weight loss through appetite reduction and increased satiety
May improve insulin sensitivity and overall metabolic health
Explored for reducing cardiovascular and obesity-related risk factors in appropriate patient populations
Research continues to evaluate additional therapeutic applications, including metabolic and liver diseases
Tirzepatide
History
Tirzepatide is a synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It was developed to improve blood glucose control while also promoting weight loss through multiple metabolic pathways.
Research Use
Researchers study Tirzepatide for its potential effects on:
Blood glucose regulation
Weight management
Appetite control
Insulin sensitivity
Cardiometabolic health
Body composition
Clinical Highlights
Studied for improving blood sugar control by enhancing glucose-dependent insulin secretion
Investigated for promoting significant weight loss through appetite reduction and increased satiety
May improve insulin sensitivity and overall metabolic health
Explored for reducing cardiovascular and obesity-related risk factors in appropriate patient populations
Research continues to evaluate additional therapeutic applications, including metabolic and liver diseases